跳至主要内容
临床试验/NCT01758094
NCT01758094已完成不适用

Plasma RBP Levels in Patients With Idiopathic Hypogonadotrophic Hypogonadism

Gulhane School of Medicine1 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2008年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
25
试验地点
1
主要终点
Retinol binding protein 4, hs-CRP levels in patients with idiopathic hypogonadotrophic hypogonadism

研究概览

简要总结

The aim of the present study was to demonstrate the RBP4 levels, association of RBP4 with insulin resistance and influence of testosterone treatment on this cytokine in patients with idiopathic hypogonadotropic hypogonadism.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
19 Years 至 26 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • decreased serum testosterone concentration below the normal range (serum T < 300ng/dL), FSH and LH levels within or below the normal range, absence of a pituitary or hypothalamic mass lesions on MRI, presence of gonadotropin response to repetitive doses of GnRH, normal smell test and normal karyotypes

排除标准

  • previous androgen treatment, history of smoking, presence of bilateral anorchia, intellectual deficiency, diabetes mellitus, arterial hypertension or dyslipoproteinemia, medication of any kind and drug abuse. Because of possible confounding effects, patients with other hormone deficiencies were excluded.

研究组 & 干预措施

Hypogonadotropic hypogonadism patients

Treatment naive 25 patients with idiopathic hypogonadotrophic hypogonadism

干预措施: Sustanon 250 mg ampule (Testosterone esters) (Drug)

结局指标

主要结局

Retinol binding protein 4, hs-CRP levels in patients with idiopathic hypogonadotrophic hypogonadism

时间窗: 2008-2012

次要结局

  • Effect of testosterone treatment on retinol binding globulin 4 and hs-CRP levels in patients with hypogodotrophic hypogonadism(2008-2012)

研究者

发起方
Gulhane School of Medicine
申办方类型
Other
责任方
Principal Investigator
主要研究者

Aydogan Aydogdu

MD

Gulhane School of Medicine

研究点 (1)

Loading locations...

相似试验